Abstract. Quantitative examinations evaluating the effects of CO 2 insufflation on residual gas in the gastrointestinal tract following colorectal endoscopic submucosal dissection (ESD) are lacking. The present study aimed to assess whether CO 2 insufflation could decrease the amount of residual gas in the gastrointestinal tract following ESD in patients with colorectal neoplasms. Computed tomography (CT) was used to objectively examine whether CO 2 insufflation during colorectal ESD reduced residual gas levels in the gastrointestinal tract following ESD. A total of 83 patients who underwent colorectal ESD between January and December 2009 at Gifu University Hospital (Gifu, Japan) were enrolled. Following exclusion of 17 patients with chronic pulmonary dysfunction, 66 patients were randomized into a CO 2 insufflation group (n=34) and an air insufflation group (n=32). The level of residual gas and the presence of transmural and free-air leaks following ESD were evaluated in both groups using CT. Transcutaneous CO 2 tension (PtcCO 2 ) and ESD-related complications were also compared between the groups. CT measurements of the major and minor axes of the cecal lumen, and of the terminal ileum diameter, indicated the level of residual gas following ESD to be significantly reduced in the CO 2 insufflation group compared with the air insufflation group (P<0.001). Neither the incidences of ESD-related complications, including post-procedure hemorrhage and air leak, nor the abnormalities in vital signs differed between the groups. No significant between-group differences were identified in the baseline and peak PtcCO 2 levels during ESD or in the median PtcCO 2 following ESD. In conclusion, CO 2 insufflation during colorectal ESD was effective in reducing residual gas in the gastrointestinal tract following ESD.
Introduction
Colorectal cancer is among the most prevalent malignancies worldwide, and therefore effective and minimally invasive procedures are required to reduce the incidence rate of this malignancy (1, 2) . More recently, utilization of colorectal endoscopic submucosal dissection (ESD) as a minimally invasive treatment for en bloc resection of large superficial neoplasms has become a favored method (3) . However, the risk of complication is higher than in gastric ESD as the wall of the colon is thin and operability is limited. In addition, colorectal ESD generally requires a long procedure time due to its technical difficulty (4, 5) . Therefore, a high level of gas enters the colonic lumen. This is associated with aggravation of subjective symptoms, such as abdominal pain, discomfort and distention, and an increased risk of severe problems, including pneumoderma, pneumothorax, abdominal compartment syndrome and air embolism (6) (7) (8) (9) (10) (11) (12) (13) (14) .
The safety and efficacy of CO 2 insufflation during ESD for lesions of the esophagus and stomach have been demonstrated in several randomized controlled trials (15) (16) (17) (18) (19) (20) (21) . A pilot study also reported that CO 2 insufflation was safe and effective during colorectal ESD (15) . As CO 2 is absorbed faster than air and is rapidly eliminated through the lungs, CO 2 insufflation is expected to reduce residual gas in both the small and large bowels following ESD, and consequently reduce the abdominal symptoms and complications associated with ESD (15, (22) (23) (24) (25) (26) (27) (28) (29) (30) . However, to the best of our knowledge, detailed and quantitative examinations evaluating the effects of CO 2 insufflation on residual gas in the gastrointestinal tract following colorectal ESD have not been performed.
The aim of the present study was to assess whether CO 2 insufflation could decrease the level of residual gas in the gastrointestinal tract following ESD in patients with colorectal neoplasms. All patients received an abdominal computed tomography (CT) examination immediately following colorectal ESD, and the level of residual gas in the gastrointestinal tract following ESD was objectively evaluated by measuring the axes of the cecal lumen and the diameter of the terminal ileum lumen. The safety of CO 2 insufflation was also assessed by measuring the levels of transcutaneous CO 2 tension (PtcCO 2 ) and evaluating the development of ESD-related complications such as air leaks.
Materials and methods
Patients. Between January and December 2009, all consecutive patients undergoing colorectal ESD at Gifu University Hospital (Gifu, Japan), were screened for the present study. Colorectal ESD was indicated for lesions that required endoscopic en bloc resection, despite this technique being difficult to use for endoscopic mucosal resection or polypectomy.
Patients with one or more of the following conditions were excluded: (i) They exhibited chronic pulmonary dysfunction defined as a forced expiratory volume in 1.0 sec/forced vital capacity of <70% or a vital capacity of <80%; (ii) they were unable to understand the consent information required for participation; and/or (iii) they refused to participate in the study. The study protocol was approved by the institutional Ethics Committee of Gifu University Hospital (ethical approval no. 28-104). All eligible individuals provided written informed consent prior to study enrollment. Randomization was conducted using a random number list, and patients were divided into two groups, namely a CO 2 insufflation group (CO 2 group) and an air insufflation group (air group).
ESD procedures and examination schedule for study events prior to and following ESD. ESD was conducted in the afternoon on the day of admission. Prior to inserting the colonoscope, 5.0-10.0 mg diazepam (Cercine ® ; Takeda Pharmaceutical Company, Ltd., Tokyo, Japan), 7.5-15.0 mg pentazocine (Pentagin ® ; Daiichi Sankyo Co., Ltd., Tokyo, Japan) and 12.5-25.0 mg hydroxyzine (Atarax-P ® ; Phizer Japan, Inc., Tokyo, Japan) were injected intravenously for induction of anesthesia and analgesia. As necessary, 5.0 mg diazepam or 7.5 mg pentazocine and 12.5 mg hydroxyzine were administered repeatedly for deep sedation; when patients opened their eyes or moved their body, the patients were considered to be out of deep sedation and received the additional injections. The ESD procedures were performed using a colonoscope and water jet (PCF-Q260J; Olympus Medical Systems; Olympus Corporation, Tokyo, Japan). The colorectal lesions were resected using either a DualKnife (KD-650Q) or FlexKnife (KD-630L; both from Olympus Corporation). A 0.4% high-molecular-weight hyaluronic acid solution containing 0.001% epinephrine was injected into the submucosal layer to raise the lesion. The mucosal layer around the lesion was cut circumferentially; subsequently, the submucosal layer was directly dissected with the DualKnife or FlexKnife. If possible, the post-ESD ulcer was closed using clips; otherwise, exposed blood vessels were clipped to reduce the risk of active bleeding. Circulation vitals, including systolic and diastolic blood pressures, heart rate and transcutaneous oxygen saturation (SpO 2 ) were measured with a bedside monitor (BSM-4101; Nihon Kohden Corporation, Tokyo, Japan) at the start of the procedure, every 5 min during the procedure, and at the end of the procedure. On the second hospital day, blood tests for white blood cell (WBC) count and C-reactive protein (CRP) were performed, and the highest axillary temperature during the total hospital stay was recorded. WBC count was measured with an automated hematology analyzer (XE-2100; Sysmex Corporation, Kobe, Japan) and CRP was measured with an automatic biochemical analyzer (JCA-BM2250; JEOL, Ltd., Tokyo, Japan) with use of a CRP kit (CRP Latex X2 NX ® ;
Denka Seiken Co. Ltd., Tokyo, Japan), according to the manufacturer's instructions.
CO 2 insufflation and transcutaneous gas analysis. CO 2 was administered using a CO 2 regulation unit (OLYMPUS UCRTM; Olympus Corporation). PtcCO 2 was continuously measured from the time of insertion of the colonoscope until the end of the procedure by using a CO 2 sensor kit (TOSCA measurement system and TOSCA 500 monitor; Linde Medical Sensors Ag, Basel, Switzerland). The low-flow gas tube (MAJ-1742, Olympus Corporation) of the UCR was used for CO 2 insufflation, which was set at a constant rate of 1.4 l/min for all patients, as reported previously (31) .
Evaluation of CT examination. CT examination of the abdomen and pelvis was performed immediately following ESD using a 16-MDCT device (LightSpeed 16; GE Healthcare Life Sciences, Little Chalfont, UK) with a fixed tube voltage of 120 kVp and an automatic tube current modulation program (3D mA modulation; GE Healthcare Life Sciences). The operational parameters of the scanner were set to noise index, 10.0 HU at 5 mm slice thickness; collimation, 1.25 mm; detector configuration, 16x1.25 mm; table feed, 27.5 mm/rotation; pitch, 1.37:1; field of view, 32x32 cm; gantry rotation time, 0.5 sec; acquisition time, 12.7 sec. All transverse CT images were reconstructed at 5 mm section thickness with a standard reconstruction algorithm. CT images were analyzed using Advantage Workstation v4.6 software (GE Healthcare Life Sciences). To evaluate the amount of residual gas in the gastrointestinal tract following ESD, a scan was performed at the level of the ileocecal valve, and the major and minor axes of the cecal lumen and the diameter of the terminal ileum lumen were measured. A small level of focal free air close to the colonic wall of the resected lesion was defined as a transmural air leak and a high level of free air reaching the surface of the liver was defined as free air (32, 33) .
Definitions of outcome parameters and complications. The operation time was measured from the start of injection into the submucosal layer until the end of the procedure. A diagnosis of perforation was made by direct endoscopic observation during ESD. Post-procedure hemorrhage was diagnosed with clinical evidence of bleeding following ESD, as shown by repetitive bloody bowel discharges that required endoscopic treatment.
Statistical analysis. All the variables in the present study are described as the number of patients (%) or the median (range).
Fisher's exact test was used to compare differences in categorical variables between the two groups when required, and the non-parametric Mann-Whitney U test was used to compare continuous variables. Two-sided P<0.05 was considered to indicate statistically significant differences for all tests. All statistical analyses were performed using JMP v12 (SAS Institute, Inc., Cary, NC, USA).
Results

Patient and procedure characteristics.
A total of 83 patients underwent colorectal ESD during the study period. Among them, 17 patients were excluded due to presentation of chronic pulmonary dysfunction; the remaining 66 patients were enrolled in the present study. The enrolled subjects were randomized into two groups: A total of 34 patients received CO 2 insufflation (CO 2 group) and 32 patients received air insufflation (air group; Fig. 1 ). Baseline characteristics and related factors for each group are listed in Table I . The median age was 65.0 (34.0-87.0) years in the CO 2 group and 65.5 (34.0-86.0) years in the air group. No significant differences in age, sex, en bloc resection rate, location of the colorectal lesion, histopathological type, tumor size, histological depth, resection size or histopathologically curative resection rate between the groups were identified. The median procedure time was 35 (10-163) and 30 (9-94) min and the rate of clip closure for the post-ESD ulcer was 44.1 and 53.1% in the CO 2 and air groups, respectively; neither of these differed significantly between the groups.
Presence of residual gas in the gastrointestinal tract evaluated by CT examination. Representative CT images of patients in the two groups are presented in Fig. 2 . In the air group, marked intestinal dilatation of the cecum and terminal ileum was observed compared with the CO 2 group. The findings of the CT examination following ESD are summarized in Table II . The median major (21.8 vs. 56.3 mm, P<0.001) and minor (13.4 vs. 36.6 mm, P<0.001) axes of the cecal lumen at the level of the ileocecal valve were significantly lower in the CO 2 group compared with the air group. In addition, the median diameter of the terminal ileum lumen was significantly lower in the CO 2 group compared with that in the air group (5.0 vs. 16.4 mm, P<0.001). These findings demonstrated the effects of CO 2 insufflation on the diminution of residual gas in the bowel following colorectal ESD.
The presence of free air was indicated in 1 patient (2.9%) in the CO 2 group and 3 patients (9.4%) in the air group. Transmural air leak was also observed in 8 patients (23.5%) in the CO 2 group and 2 patients (6.3%) in the air group; however, no significant differences were identified in the incidence rates of these air leaks between the groups.
PtcCO 2 and vital signs prior to and following ESD.
The PtcCO 2 and vital signs (blood pressure, heart rate and SpO 2 ) of patients recorded during ESD are listed in Table III Circulation vitals, including systolic and diastolic blood pressures and heart rate prior to and following ESD, did not differ significantly between the groups. In addition, significant elevation or lowering of blood pressures and heart rate during ESD was not observed in either group. The median minimum SpO 2 levels did not differ significantly between the groups, being 98.0 (94.0-100.0) % in the CO 2 group and 98.5 (95.0-100.0) % in the air group (Table III) .
Incidence of post-ESD complications and hospital stay.
ESD-related complications and the length of hospital stay are summarized in Table IV . No significant differences were observed in body temperature, incidence of post-ESD hemorrhage or the length of stay between the CO 2 and air groups.
Furthermore, no significant differences were identified in serum CRP levels or WBC counts on day 1 after ESD. A patient in the CO 2 group presented a complication of perforation during ESD, but the lesion was closed using clips. The patient did not require emergency surgery and was discharged 4 days after ESD. No cases of cardiopulmonary adverse events occurred in either group.
Discussion
ESD of colorectal tumors can provide clinical benefits as it enables en bloc resection of large superficial neoplasms (32, 34) . However, one of the problems with this procedure is the severe intraoperative and post-operative abdominal discomfort and distention caused by air infusion (15) . CO 2 is absorbed by the bowel mucosa approximately 100 times faster than air and is rapidly eliminated through the lungs (35) . This may be associated with the superior recovery quality of CO 2 insufflation compared with room air insufflation in colonoscopy (36) . Therefore, when compared with air insufflation, CO 2 insufflation is expected to reduce the volume of residual gas following ESD, which is a primary cause of patient discomfort associated with this procedure, and consequently prevent the development of abdominal symptoms and problems associated with ESD (5, (22) (23) (24) (25) (26) (27) (28) (29) (30) .
The results of the present randomized trial indicated that CO 2 insufflation during colorectal ESD significantly reduced the volume of residual bowel gas compared with air insufflation. Several studies have reported the efficacy of CO 2 insufflation during various types of endoscopic Continuous variables are presented as the median (range). ESD, endoscopic submucosal dissection. Figure 2 . Representative computed tomography images at the level of the ileocecal valve of patients in the (A) air insufflation group and (B) CO 2 insufflation group. Marked intestinal dilatation of the cecum and terminal ileum was observed in the air insufflation group, while these dilatations were improved in the CO 2 insufflation group. Red two-way arrow, major axis of the cecal lumen; white two-way arrow, minor axis of the cecal lumen; yellow two-way arrow, lumen diameter of the terminal ileum.
procedures (24, 25, 28, 37, 38) . However, few studies have objectively evaluated the level of residual bowel gas following this procedure. Chen et al (39) , observed that CO 2 insufflation significantly reduced the volume of residual bowel gas compared with air insufflation following colonoscopy by using abdominal radiography. To the best of our knowledge, the present study is the first to objectively evaluate the degree of bowel distention following colorectal ESD using CT examination. The present study identified the median major and minor axes of the cecal lumen at the level of the ileocecal valve to be significantly lower in the CO 2 group than in the air group (P<0.001). In addition, the median diameter of the terminal ileum lumen was significantly lower in the CO 2 group than in the air group (P<0.001). These findings suggest that CO 2 insufflation significantly reduced the volume of residual bowel gas compared with air insufflation following colorectal ESD. In the present study, there was no significant difference in the peak PtCO 2 , which is a useful marker for evaluating CO 2 retention (40), between the CO 2 and air insufflation groups.
No marked adverse events, such as CO 2 narcosis, air embolism, SpO 2 depression or hemodynamic abnormality, occurred in either group. In addition, post-procedure CT demonstrated no significant difference in the incidence of free air or transmural air leak between the groups. As CO 2 insufflation can reduce the volume of residual bowel gas, it may avoid an increase in intra-bowel pressure and improve patient safety. These results suggest that CO 2 insufflation during colorectal ESD is a safer alternative to air insufflation.
In the present study, patients with chronic pulmonary dysfunction were excluded, as the safety of CO 2 insufflation during colorectal ESD has not been established for such patients. However, a recent study demonstrated that CO 2 insufflation during gastric ESD was safe for patients with pulmonary dysfunction under conscious sedation (31) . CO 2 insufflation during colorectal ESD is also safe for patients with obstructive ventilatory disturbance (41) . The number of patients, particularly elderly patients, suffering from complications including chronic pulmonary dysfunction is increasing; therefore, a clinical trial that clarifies the safety and efficacy of CO 2 insufflation during colorectal ESD in such patients should be conducted. The present study had a number of limitations. First, the study was a single-center study with a relatively small sample size. Therefore, multi-center studies with larger sample sizes should be performed to confirm the present results. These studies may also be useful for assessing whether CO 2 insufflation may reduce the risk of ESD-related complications, such as transmural air leak and perforation, compared with conventional air insufflation. It should be also verified in future studies whether CO 2 insufflation relieved abdominal pain and improved the degree of patients' satisfaction. Second, the volume of insufflated gas during the ESD procedure could not be measured. However, it is probable that there was not much difference in the volume of insufflated gas between the CO 2 and air groups since the flow volume was the same (1.4 L/min) in both groups and no significant difference was observed in the median procedure time between the groups.
Despite these limitations, it should be emphasized that reduction of the patient's residual gastrointestinal gas following ESD can decrease abdominal fullness; this is associated with a high level of patient satisfaction (35) . In conclusion, the present results suggest that CO 2 insufflation during colorectal ESD is effective, as it may significantly reduce residual gas in the gastrointestinal tract and therefore increase the satisfaction and comfort of patients who have undergone ESD.
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